KAPPEL, BEN ARPAD
KAPPEL, BEN ARPAD
Dipartimento di Medicina dei sistemi
2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease
2018-01-01 Cardellini, M; Ballanti, M; Davato, F; Cardolini, I; Guglielmi, V; Rizza, S; Pecchioli, C; Casagrande, V; Mavilio, M; Porzio, O; Legramante, Jm; Ippoliti, A; Farcomeni, A; Sbraccia, P; Menghini, R; Dumas, Me; Kappel, Ba; Federici, M
Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia
2023-01-01 Kappel, Ba; De Angelis, L; Puetz, A; Ballanti, M; Menghini, R; Marx, N; Federici, M
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
2020-03-13 Kappel, Ba; De Angelis, L; Heiser, M; Ballanti, M; Stoehr, R; Goettsch, C; Mavilio, M; Artati, A; Paoluzi, Oa; Adamski, J; Mingrone, G; Staels, B; Burcelin, R; Monteleone, G; Menghini, R; Marx, N; Federici, M
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027))
2016-01-01 Mavilio, M; Marchetti, V; Fabrizi, M; Stöhr, R; Marino, A; Casagrande, V; Fiorentino, L; Cardellini, M; Kappel, Ba; Monteleone, I; Garret, C; Mauriello, A; Monteleone, G; Farcomeni, A; Burcelin, R; Menghini, R; Federici, M
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker
2021-01-01 Kappel, Ba; Moellmann, J; Thiele, K; Rau, M; Artati, A; Adamski, J; Ghesquiere, B; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M
Non-targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function
2022-01-01 Puetz, A; Artati, A; Adamski, J; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M; Kappel, Ba
The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism
2017-01-01 Möllmann, J; Kahles, F; Lebherz, C; Kappel, Ba; Baeck, C; Tacke, F; Werner, C; Federici, M; Marx, N; Lehrke, M
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2018 | 2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease | Cardellini, M; Ballanti, M; Davato, F; Cardolini, I; Guglielmi, V; Rizza, S; Pecchioli, C; Casagrande, V; Mavilio, M; Porzio, O; Legramante, Jm; Ippoliti, A; Farcomeni, A; Sbraccia, P; Menghini, R; Dumas, Me; Kappel, Ba; Federici, M | Articolo su rivista | |
| 1-gen-2023 | Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia | Kappel, Ba; De Angelis, L; Puetz, A; Ballanti, M; Menghini, R; Marx, N; Federici, M | Articolo su rivista | |
| 13-mar-2020 | Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment | Kappel, Ba; De Angelis, L; Heiser, M; Ballanti, M; Stoehr, R; Goettsch, C; Mavilio, M; Artati, A; Paoluzi, Oa; Adamski, J; Mingrone, G; Staels, B; Burcelin, R; Monteleone, G; Menghini, R; Marx, N; Federici, M | Articolo su rivista | |
| 1-gen-2016 | Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) | Mavilio, M; Marchetti, V; Fabrizi, M; Stöhr, R; Marino, A; Casagrande, V; Fiorentino, L; Cardellini, M; Kappel, Ba; Monteleone, I; Garret, C; Mauriello, A; Monteleone, G; Farcomeni, A; Burcelin, R; Menghini, R; Federici, M | Articolo su rivista | |
| 1-gen-2021 | Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker | Kappel, Ba; Moellmann, J; Thiele, K; Rau, M; Artati, A; Adamski, J; Ghesquiere, B; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M | Articolo su rivista | |
| 1-gen-2022 | Non-targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function | Puetz, A; Artati, A; Adamski, J; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M; Kappel, Ba | Articolo su rivista | |
| 1-gen-2017 | The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism | Möllmann, J; Kahles, F; Lebherz, C; Kappel, Ba; Baeck, C; Tacke, F; Werner, C; Federici, M; Marx, N; Lehrke, M | Articolo su rivista |